- Home
- ESPR vs DJCO Comparison
ESPR vs DJCO Comparison
Compare ESPR & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESPR | DJCO |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 838.4M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESPR | DJCO |
|---|---|---|
| Price | $3.39 | $566.88 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 64.5K |
| Earning Date | 03-03-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.52 |
| EPS | N/A | ★ 81.41 |
| Revenue | ★ $303,802,000.00 | $87,700,000.00 |
| Revenue This Year | $27.49 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.89 |
| Revenue Growth | 2.83 | ★ 25.41 |
| 52 Week Low | $0.69 | $348.63 |
| 52 Week High | $4.18 | $674.75 |
Technical Indicators
Market Signals| Indicator | ESPR | DJCO |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 46.41 |
| Support Level | $3.16 | $508.69 |
| Resistance Level | $3.64 | $587.00 |
| Average True Range (ATR) | 0.21 | 35.78 |
| MACD | 0.01 | -10.26 |
| Stochastic Oscillator | 61.94 | 35.19 |
Price Performance
Historical ComparisonAbout ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.